203
Views
21
CrossRef citations to date
0
Altmetric
Research Article

Analysis of myosmine, cotinine and nicotine in human toenail, plasma and saliva

, , &
Pages 278-284 | Received 30 Jan 2009, Accepted 10 Mar 2009, Published online: 01 Jun 2009
 

Abstract

Myosmine is a minor tobacco alkaloid with widespread occurrence in the human diet. Myosmine is genotoxic in human cells and is readily nitrosated and peroxidated yielding reactive intermediates with carcinogenic potential. For biomonitoring of short-term and long-term exposure, analytical methods were established for determination of myosmine together with nicotine and cotinine in plasma, saliva and toenail by gas chromatography–mass spectrometry (GC/MS). Validation of the method with samples of 14 smokers and 10 non-smokers showed smoking-dependent differences of myosmine in toenails (66 ± 56 vs 21 ± 15 ng g−1, p <0.01) as well as saliva (2.54 ± 2.68 vs 0.73 ± 0.65 ng ml−1, p <0.01). However, these differences were much smaller than those with nicotine (1971 ± 818 vs 132 ± 82 ng g−1, p <0.0001) and cotinine (1237 ± 818 vs <35 ng g−1) in toenail and those of cotinine (97.43 ± 84.54 vs 1.85 ± 4.50 ng ml−1, p <0.0001) in saliva. These results were confirmed in plasma samples from 84 patients undergoing gastro-oesophageal endoscopy. Differences between 25 smokers and 59 non-smokers are again much lower for myosmine (0.30 ± 0.35 vs 0.16 ± 0.18 ng ml−1, p <0.05) than for cotinine (54.67 ± 29.63 vs 0.61 ± 1.82 ng ml−1, p <0.0001). In conclusion, sources other than tobacco contribute considerably to the human body burden of myosmine.

Acknowledgement

This study was supported in part by Philip Morris USA Inc. and Philip Morris International.

Declaration of interest: The authors report no conflicts of interest. The authors alone are responsible for the content and writing of the paper.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.